Newsletter
Drugs in WAR Medical Psychedelics News

Ukraine Explores MDMA for PTSD Amid War Trauma

Ukraine Explores Psychedelic-Assisted Therapies for PTSD Amid War Trauma
Written by PsychePen

Ukraine considers becoming a research center for MDMA and other psychedelics to address the PTSD crisis caused by the ongoing war.

Summary: Dmytro Gurin, a Ukrainian MP, has proposed that Ukraine become a leading research center for psychedelic-assisted therapies to treat the soaring rates of post-traumatic stress disorder (PTSD) among its population affected by Russia’s invasion. With an estimated 3 to 4 million Ukrainians currently living with PTSD, and up to 57 percent of the population at risk, Gurin is seeking EU support to develop nationwide clinical trials for MDMA-assisted therapy.

How could MDMA transform the treatment of PTSD in war-torn regions like Ukraine?

The ongoing war in Ukraine has led to a mental health crisis, with millions suffering from PTSD. In response, Ukrainian MP Dmytro Gurin, a member of President Volodymyr Zelenskyy’s Servant of the People party and the health committee, has called on the EU to assist Ukraine in becoming a hub for research on psychedelic-assisted therapies. Gurin’s proposal focuses on using MDMA, the chemical found in ecstasy, as a potential treatment for PTSD.

Gurin suggests that Ukraine’s large population of trauma sufferers makes it an ideal location for researching MDMA-assisted therapies. He advocates for EU financial support to conduct a nationwide clinical trial, testing MDMA-assisted therapy as a primary treatment for trauma, rather than as a last resort. This approach is driven by the sheer number of patients needing treatment.

The meeting, hosted by MEPs Tomáš Zdechovský and Radka Maxová from the MEPs action group for the medical use of psychedelics, discussed how MDMA has shown promise in helping PTSD patients in clinical trials. Australia has already authorized its use, and the U.S. and EU are considering similar steps.

Implementing such a trial in Ukraine would not require a change in law but a decree from the Cabinet of ministers. There is already agreement between ministries on various aspects, from production to consumption of psychedelics for research purposes.

However, challenges remain, including a shortage of trained therapists. Gurin proposes establishing a training center in Uzhhorod, near the Slovakian border, to train Ukrainian therapists specifically for war-related trauma cases.

Political opposition to classified drugs for treating health conditions is another hurdle. The Ukrainian parliament is currently debating a medical cannabis bill, facing pushback from opposition parties. Despite this, the health committee recently recommended the bill for a second reading.

President Zelenskyy has expressed the need for the best and newest technologies to deal with trauma, indicating potential support for psychedelic-assisted therapies. These therapies represent the first new drugs in years showing promise for severe mental health conditions.

Source: Politico


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.

Have anything to add? Your voice matters! Join the conversation and contribute your insights and ideas below.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About the author

PsychePen

PsychePen is Cannadelics' main news editor. As a self-taught wellness expert with a unique perspective on drugs, cannabis, and psychedelics, PsychePen is known for his unique style: short and informative articles, easy-to-read and to-the-point. PsychePen is also one of our most successful AI authors. so its keep on improving.